Exciting news! A groundbreaking study using BIOMIMESYS® for breast cancer metastasis research has been published in the Experimental Hematology & Oncology Journal. The study, titled “ProNGF promotes brain metastasis through TrkA/EphA2 induced Src activation in triple negative breast cancer cells” by Cicero, Trouvilliez, et al. (2023), emphasizes the role of Extracellular Matrix organ specificity in […]
PRESS RELEASE: Successfully Seeding a Broken Heart – Heartseed Inc. succeeds in first human dosing of cardiomyocyte spheroids derived from allogeneic iPS Cells in PhⅠ/Ⅱ clinical trial for advanced heart failure utilizing iMatrix™ family of products. Heartseed Inc, announced that Heartseed successfully dosed the first patient with HS-001, an investigational iPS cell derived therapy for […]
Laminins are cell adhesion proteins Basement membrane component Heterotrimer composed of α, β, and γ chains At least 12 isoforms in human Interacts with cell surface receptors, integrins Promotes cell survival and regulates cellular behaviors (migration and polarization) and fate (differentiation) Combination of laminins and cell types in vivo Biological functions of laminins are exerted […]
Iwai North America Inc. executed a distributor’s agreement with Cell Science & Technology Institute Inc. (CSTI). CSTI is known for their quality culture medium for the Immuno-therapy and stem cells. The addition of these culture media to Iwai’s current product line up, creates a synergy among the products, thus providing researches reliable quality products for […]
BIOMIMESYS® hydroscaffold technology based on crosslinking Hyaluronic Acid (HA) and extracellular matrix compounds reproduces tissue microenvironment in 3D. In this webinar we will focus on BIOMIMESYS® Adipose Tissue and its applications. Due to the tunable mechanical and chemical properties, this matrix possess biophysical characteristics similar to natural tissue and represent highly effective matrice for the […]
Iwai North America Inc. executed a marketing collaboration agreement with Zenogen Pharma. Zenogen Pharma is known for their cryopreservation medium, CELLBANKER®. With over 80% cell viability for most cell lines along with +10 years of viability data, it is one of the trusted cryopreservation medium on the market.